Zhou et al. conducted a retrospective multicenter study of 191 patients with laboratory-confirmed COVID-19 infection and reported elevated IL6 levels and severe lymphopenia in non-survivors than in the survivors. This evidence concerns the gene IL6 and lymphopenia.